AMBRISENTAN is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Avkare. The primary component is Ambrisentan.
| Product ID | 42291-018_b6c019e2-3f31-061d-e053-2a95a90a89d3 |
| NDC | 42291-018 |
| Product Type | Human Prescription Drug |
| Proprietary Name | AMBRISENTAN |
| Generic Name | Ambrisentan |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-12-18 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA208354 |
| Labeler Name | AvKARE |
| Substance Name | AMBRISENTAN |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Endothelin Receptor Antagonist [EPC],Endothelin Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-12-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-4270 | Ambrisentan | ambrisentan |
| 0378-4271 | Ambrisentan | ambrisentan |
| 0591-2405 | Ambrisentan | Ambrisentan |
| 0591-2406 | Ambrisentan | Ambrisentan |
| 42291-018 | AMBRISENTAN | AMBRISENTAN |
| 42291-019 | AMBRISENTAN | AMBRISENTAN |
| 42794-051 | AMBRISENTAN | AMBRISENTAN |
| 42794-052 | AMBRISENTAN | AMBRISENTAN |
| 47335-236 | ambrisentan | ambrisentan |
| 47335-237 | ambrisentan | ambrisentan |
| 49884-353 | Ambrisentan | Ambrisentan |
| 49884-354 | Ambrisentan | Ambrisentan |
| 59651-494 | ambrisentan | ambrisentan |
| 59651-495 | ambrisentan | ambrisentan |
| 60505-4552 | Ambrisentan | AMBRISENTAN |
| 60505-4553 | Ambrisentan | AMBRISENTAN |
| 69097-386 | Ambrisentan | Ambrisentan |
| 69097-387 | Ambrisentan | Ambrisentan |
| 70710-1179 | Ambrisentan | Ambrisentan |
| 70710-1180 | Ambrisentan | Ambrisentan |
| 70771-1363 | Ambrisentan | Ambrisentan |
| 70771-1364 | Ambrisentan | Ambrisentan |
| 76282-684 | Ambrisentan | Ambrisentan |
| 76282-685 | Ambrisentan | Ambrisentan |
| 61958-0801 | Letairis | AMBRISENTAN |
| 61958-0802 | Letairis | AMBRISENTAN |